Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Compare Drugs in HMG-CoA Reductase Inhibitor [EPC]

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Drug	Reports	Deaths	Death Rate	Hosp.	Life-Threat.	Avg Age	% Female
ATORVASTATIN	79,519	4,992	6.3%	24,078	3,790	64.4 yrs	58.5%
ROSUVASTATIN	36,332	1,536	4.2%	11,195	1,865	66.1 yrs	54.9%
SIMVASTATIN	27,079	2,792	10.3%	8,824	1,824	66.6 yrs	47.5%
PRAVASTATIN	8,284	923	11.1%	2,338	441	65.5 yrs	55.0%
PITAVASTATIN	2,344	346	14.8%	351	78	65.1 yrs	56.0%
FLUVASTATIN	1,815	323	17.8%	515	131	61.6 yrs	48.8%
LOVASTATIN	1,387	204	14.7%	287	32	60.2 yrs	55.9%

Head-to-Head Comparisons

ATORVASTATIN vs ROSUVASTATIN ATORVASTATIN vs SIMVASTATIN ATORVASTATIN vs PRAVASTATIN ATORVASTATIN vs PITAVASTATIN ROSUVASTATIN vs SIMVASTATIN ROSUVASTATIN vs PRAVASTATIN ROSUVASTATIN vs PITAVASTATIN SIMVASTATIN vs PRAVASTATIN SIMVASTATIN vs PITAVASTATIN PRAVASTATIN vs PITAVASTATIN

← Back to HMG-CoA Reductase Inhibitor [EPC] Class side effects →